Axos Financial (NYSE:AX – Get Free Report) had its target price dropped by Wedbush from $80.00 to $75.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. Wedbush’s target price would suggest a potential upside of 16.39% from the company’s previous close.
Several other research firms also recently weighed in on AX. Keefe, Bruyette & Woods downgraded Axos Financial from an “outperform” rating to a “market perform” rating and set a $79.00 target price for the company. in a research report on Wednesday, July 31st. Piper Sandler lifted their price objective on shares of Axos Financial from $68.00 to $84.00 and gave the company an “overweight” rating in a research note on Wednesday, July 31st. Finally, Raymond James upped their price target on Axos Financial from $67.00 to $81.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 31st. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $79.75.
Axos Financial Trading Down 2.2 %
Axos Financial (NYSE:AX – Get Free Report) last announced its earnings results on Tuesday, July 30th. The company reported $1.80 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.80. Axos Financial had a return on equity of 18.57% and a net margin of 23.96%. The company had revenue of $484.29 million for the quarter, compared to analyst estimates of $296.02 million. During the same period in the prior year, the company posted $1.50 EPS. As a group, research analysts forecast that Axos Financial will post 7.22 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other news, EVP Andrew J. Micheletti sold 5,197 shares of the firm’s stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $63.13, for a total value of $328,086.61. Following the sale, the executive vice president now directly owns 424,149 shares of the company’s stock, valued at $26,776,526.37. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 4.82% of the company’s stock.
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in AX. Norges Bank bought a new position in Axos Financial in the fourth quarter valued at $21,573,000. PNC Financial Services Group Inc. lifted its position in shares of Axos Financial by 8.0% during the 4th quarter. PNC Financial Services Group Inc. now owns 5,318 shares of the company’s stock worth $290,000 after buying an additional 394 shares during the last quarter. Quest Partners LLC bought a new stake in shares of Axos Financial during the 4th quarter valued at approximately $100,000. Hsbc Holdings PLC acquired a new position in shares of Axos Financial in the fourth quarter valued at approximately $1,809,000. Finally, TFO Wealth Partners LLC raised its holdings in Axos Financial by 90,366.7% during the 4th quarter. TFO Wealth Partners LLC now owns 2,714 shares of the company’s stock worth $164,000 after purchasing an additional 2,711 shares during the last quarter. Institutional investors and hedge funds own 83.79% of the company’s stock.
Axos Financial Company Profile
Axos Financial, Inc, together with its subsidiaries, provides consumer and business banking products in the United States. It operates through two segments, Banking Business and Securities Business. The company offers deposits products, including consumer and business checking, demand, savings, time deposit, money market, zero balance, and insured cash sweep accounts.
Further Reading
- Five stocks we like better than Axos Financial
- How to Most Effectively Use the MarketBeat Earnings Screener
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What Are Dividends? Buy the Best Dividend Stocks
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- How to Capture the Benefits of Dividend Increases
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Axos Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axos Financial and related companies with MarketBeat.com's FREE daily email newsletter.